Keith Pietropaolo
Directeur Technique/Scientifique/R&D chez ATEA PHARMACEUTICALS, INC.
Postes actifs de Keith Pietropaolo
Sociétés | Poste | Début | Fin |
---|---|---|---|
ATEA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Keith Pietropaolo
Anciens postes connus de Keith Pietropaolo
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2016 | 01/12/2016 |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Directeur des opérations | 01/05/2014 | 01/01/2015 |
IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/10/2003 | 01/04/2014 |
Boston Biostatistics, Inc. | Corporate Officer/Principal | - | - |
Formation de Keith Pietropaolo
Boston College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
Boston Biostatistics, Inc. |
- Bourse
- Insiders
- Keith Pietropaolo
- Expérience